NDC 63323-276-01 - Heparin Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-276
- Requested NDC
- 63323-276-01
- Package NDCs from labels
- 63323-276-01, 63323-276-02
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2025-11-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Heparin Sodium - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-11-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-276-01 | Heparin Sodium | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 13 | |
| 63323-276-02 | Heparin Sodium | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-276-01 | ML - Milliliter | 63323-276 | f3cbd721-ee51-4362-8d0a-21b0f3434a03 | 1 | 2022-06-06 |
| 63323-276-02 | ML - Milliliter | 63323-276 | 31dbf350-2c42-43f3-b42c-bb56d4a03387 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HEPARIN SODIUM | ACTIVE INGREDIENT | ZZ45AB24CA | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| HEPARIN | ACTIVE MOIETY | T2410KM04A | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | Gland Pharma Limited | 301b19bc-21c2-4a35-9d29-569b08d855c4 | 2026-11-03 | Warnings, Adverse reactions | 1361226 1361615 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Henry Schein, Inc. | 3a998729-c912-4e21-8e49-d1e72ba6fe9e | 2026-11-02 | Warnings, Adverse reactions | NDA017029 1361226 ZZ45AB24CA |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-10-30 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-10-30 | Warnings, Adverse reactions | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5e74e26d-fe34-8784-e063-6394a90ae194 | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5ed79ba5-43a0-c323-e063-6394a90a4618 | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5eda970a-6fe4-8af3-e063-6394a90a5762 | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5edb1f1e-122d-f0da-e063-6394a90a4ccd | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIXUSA, INC. | 5ede6a14-cc47-8423-e063-6294a90a58c5 | 2026-10-29 | Warnings | 451W47IQ8X |
| Heparin Sodium | HEPARIN SODIUM | REMEDYREPACK INC. | a5fab0b1-c472-489c-ba87-2f8e53356173 | 2026-10-29 | Warnings, Adverse reactions | ZZ45AB24CA |
| Homeopathic Moon drops | ARSENIC CATION 30X, MATRICARIA CHAMOMILLA 6X, ARABICA COFFEE BEAN 12X, GELSEMIUM SEMPERVIRENS ROOT 12X, STRYCHNOS IGNATII SEED 30X, LYCOPODIUM CLAVATUM SPORE 30X, SODIUM CHLORIDE 30X, STRYCHNOS NUX VOMICA SEED 30X, VALERIAN 12C, | Historical Remedies LLP | 0e7972a5-a930-4a52-8896-02ce810fa90b | 2026-10-29 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Cardinal Health 107, LLC | 97007188-43fe-416c-a87b-6ccc4d9ae2ec | 2026-10-28 | Adverse reactions | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | Sportpharm LLC | b809de66-be11-46c8-b1b4-ab32bc6faee2 | 2026-10-28 | Warnings, Adverse reactions | 451W47IQ8X |
| QUALITY CHOICE SALINE | PLUS SOOTHING ALOE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 4ae4e88a-aaa5-4195-bedc-622fd5cd9394 | 2026-10-28 | Warnings | 451W47IQ8X |
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2026-10-28 | Warnings | 451W47IQ8X |
| Normal Salt | SODIUM CHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | f3f09817-8a38-4aa1-956b-69d9cf695074 | 2026-10-26 | Warnings | 451W47IQ8X |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | a3041c04-0ea8-4d36-81ce-c5091c906316 | 2026-10-26 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | 8b030692-fc66-4c53-85aa-6f865e635618 | 2026-10-26 | Warnings, Adverse reactions | ZZ45AB24CA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.